pharmaphorum

SEPTEMBER 9, 2021

There’s plenty of talk about a post-COVID world right now, which can seem strange when so many places are still feeling the impact or remain in the grip of the pandemic. In his 2015 TED talk, Bill Gates surmised that a highly infectious virus, rather than a war, was our greatest risk of global catastrophe. COVID-19 hit us hard.

Patient Care 52

Patient Care Pharmaceutical Companies Pharmaceutical Companies Communication 52

European Pharmaceutical Review

FEBRUARY 2, 2023

The European Commission (EC) conducted a comprehensive assessment 1 in 2021 that revealed that 80 percent of API by volume imported into Europe comes from just five countries, with China supplying 45 percent of the API and the rest coming from India, Indonesia, US and UK. European manufacturers only increased their CEPs from 348 to 1,260.

Generic Medicine 102

Generic Medicine Packaging Documentation Pharmaceutical Companies 102

European Pharmaceutical Review

JULY 25, 2022

Criminals were able to capitalise on supply chain disruptions, industry regulations being in transition and the urgent global demand for medical products; consequently they thrived. Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact.

Packaging 85

Packaging 85

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. On 3 June, the European Union (EU) adopted a sixth round of sanctions against Russia and key individuals, including a phase-out of Russian oil.

Vaccines 122

Vaccines Packaging FDA 122

Pharmaceutical Technology

DECEMBER 15, 2022

On November 16, 2022, Medicines for Europe (MFE), the generics and biosimilars body, called for EU and national reforms to improve the security of medicine supplies, including tackling the impact of inflation on the security of essential medicine supplies with smart procurement guidelines for medicine.

Generic Medicine 98

Generic Medicine Hospitals 98

PharmaShots

MAY 9, 2023

Social Factors Generation Health: This aspect is crucial as it corresponds to the layouts of drug development requirements based on the patient population of geography. Compared to the younger generation, the geriatric population requires more drugs. The pharmaceutical industry is no exception when it comes to challenges.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Insurance Vaccines 56

PharmaShots

MAY 1, 2023

Factors like digitalization, patent expiry, growing competition, and others put direct or indirect impacts on the revenue of the companies Ever wondered, why for the past few days our feed has been brimming with layoffs news? The pharmaceutical industry is an ever-growing sector driven by innovation and astounding technology.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

PharmaShots

MAY 1, 2023

Factors like digitalization, patent expiry, growing competition, and others put direct or indirect impacts on the revenue of the companies Ever wondered, why for the past few days our feed has been brimming with layoffs news? The pharmaceutical industry is an ever-growing sector driven by innovation and astounding technology.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

Pharmaceutical Technology

MARCH 22, 2023

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MAY 23, 2023

The war in Ukraine has had a significant impact on clinical trials in Europe, exacerbating supply chain delays that were already causing multiple problems even before the Covid-19 pandemic intensified the situation. The impact of that was to ensure the security of the depot, the contents, and inventory.

Communication 52

Communication 52